J Rheum Dis.  2024 Jan;31(1):25-32. 10.4078/jrd.2023.0046.

Clinical characteristics of juvenile systemic sclerosis in Korea: 31-year single-center study

• Jeong JE
• Kim SH

• KMID: 2549633
• DOI: http://doi.org/10.4078/jrd.2023.0046

Abstract

Objective
To evaluate the clinical and laboratory characteristics, therapeutic drugs, and prognosis of juvenile systemic sclerosis (JSSc) at a single center in Korea.
Methods
This study was a retrospective analysis of patients with JSSc aged <16 years at disease onset and who were treated at our hospital between January 1992 and April 2023. All patients met the Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for JSSc, and those with localized scleroderma (morphea) were excluded.
Results
Among the 13 patients, proximal skin sclerosis (100%), Raynaud’s phenomenon (RP) (84.6%), and sclerodactyly (69.2%) were present at the time of diagnosis. The most common symptom before diagnosis was RP, which was present in 10 patients (76.9%), whereas proximal skin sclerosis was observed in only five patients (38.5%). Thirteen patients had positive anti-nuclear antibody (ANA). At the time of diagnosis, five individuals had findings suggestive of interstitial lung disease (ILD) on a pulmonary function test (PFT) or chest computed tomography (CT), two of whom were asymptomatic. During follow-up, three patients developed ILD, one developed renal dysfunction, one developed heart disease, and none died.
Conclusion
This study was the first descriptive analysis of clinical features of JSSc in South Korea. Clinical suspicion is essential for diagnosing JSSc in patients with RP, especially if ANA is positive; however, proximal skin sclerosis, which is crucial for diagnosing JSSc, was unrecognized in the early phase of the disease. PFT should be considered even if a patient is asymptomatic or has normal chest CT.

Keyword

Juvenile systemic scleroderma; Raynaud disease; Anti-nuclear antibody; Interstitial lung diseases

Reference

1. Zulian F, Woo P, Athreya BH, Laxer RM, Medsger TA Jr, Lehman TJ, et al. 2007; The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis. Arthritis Rheum. 57:203–12. DOI: 10.1002/art.22551. PMID: 17330294.

2. Herrick AL, Ennis H, Bhushan M, Silman AJ, Baildam EM. 2010; Incidence of childhood linear scleroderma and systemic sclerosis in the UK and Ireland. Arthritis Care Res (Hoboken). 62:213–8. DOI: 10.1002/acr.20070. PMID: 20191520.

3. Beukelman T, Xie F, Foeldvari I. 2018; Assessing the prevalence of juvenile systemic sclerosis in childhood using administrative claims data from the United States. J Scleroderma Relat Disord. 3:189–90. DOI: 10.1177/2397198318763701. PMID: 35382241. PMCID: PMC8892864.

4. Stevens AM, Torok KS, Li SC, Taber SF, Lu TT, Zulian F. 2019; Immunopathogenesis of juvenile systemic sclerosis. Front Immunol. 10:1352. DOI: 10.3389/fimmu.2019.01352. PMID: 31293569. PMCID: PMC6603145. PMID: 6b001f4e9b2246839768bc45975cd6bb.

5. Torok KS, Stevens AM. Petty RE, Laxer RM, Lindsley CB, Wedderburn LR, editors. 2020. Juvenile systemic sclerosis. Textbook of pediatric rheumatology. 8th ed. Elsevier;Philadelphia: p. 377–401. DOI: 10.1186/1546-0096-10-s1-a70.

6. Hawley DP, Baildam EM, Amin TS, Cruikshank MK, Davidson JE, Dixon J, et al. 2012; Access to care for children and young people diagnosed with localized scleroderma or juvenile SSc in the UK. Rheumatology (Oxford). 51:1235–9. DOI: 10.1093/rheumatology/ker521. PMID: 22344577.

7. Martini G, Foeldvari I, Russo R, Cuttica R, Eberhard A, Ravelli A, et al. 2006; Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database. Arthritis Rheum. 54:3971–8. DOI: 10.1002/art.22207. PMID: 17133611.

8. Russo RA, Katsicas MM. 2007; Clinical characteristics of children with Juvenile Systemic Sclerosis: follow-up of 23 patients in a single tertiary center. Pediatr Rheumatol Online J. 5:6. DOI: 10.1186/1546-0096-5-6. PMID: 17550632. PMCID: PMC1869029. PMID: c79172f4316644a08f11525dff8f9810.

9. Rabinovich CE. 2011; Challenges in the diagnosis and treatment of juvenile systemic sclerosis. Nat Rev Rheumatol. 7:676–80. DOI: 10.1038/nrrheum.2011.148. PMID: 21989282.

10. Sousa S, Fernandes S, Estanqueiro P, Zilhão C, Resende C, Aguiar F, et al. 2017; Juvenile systemic sclerosis: review of 17 Portuguese patients. J Scleroderma Relat Disord. 2:121–6. DOI: 10.5301/jsrd.5000242.

11. Foeldvari I, Culpo R, Sperotto F, Anton J, Avcin T, Baildam E, et al. 2021; Consensus-based recommendations for the management of juvenile systemic sclerosis. Rheumatology (Oxford). 60:1651–8. DOI: 10.1093/rheumatology/keaa584. PMID: 33147624.

12. Fernández-Codina A, Walker KM, Pope JE. Scleroderma Algorithm Group. 2018; Treatment algorithms for systemic sclerosis according to experts. Arthritis Rheumatol. 70:1820–8. DOI: 10.1002/art.40560. PMID: 29781586.

13. Scalapino K, Arkachaisri T, Lucas M, Fertig N, Helfrich DJ, Londino AV Jr, et al. 2006; Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease. J Rheumatol. 33:1004–13. PMID: 16583463.

14. Misra R, Singh G, Aggarwal P, Aggarwal A. 2007; Juvenile onset systemic sclerosis: a single center experience of 23 cases from Asia. Clin Rheumatol. 26:1259–62. DOI: 10.1007/s10067-006-0483-z. PMID: 17180299.

15. Aoyama K, Nagai Y, Endo Y, Ishikawa O. 2007; Juvenile systemic sclerosis: report of three cases and review of Japanese published work. J Dermatol. 34:658–61. DOI: 10.1111/j.1346-8138.2007.00350.x. PMID: 17727371.

16. Foeldvari I, Torok KS. 2021; Review for best practice in clinical rheumatology juvenile systemic sclerosis - updates and practice points. Best Pract Res Clin Rheumatol. 35:101688. DOI: 10.1016/j.berh.2021.101688. PMID: 33896752.

17. Foeldvari I. 2015; Update on juvenile systemic sclerosis. Curr Rheumatol Rep. 17:18. DOI: 10.1007/s11926-014-0491-y. PMID: 25761925.

18. Duffy CM, Laxer RM, Lee P, Ramsay C, Fritzler M, Silverman ED. 1989; Raynaud syndrome in childhood. J Pediatr. 114:73–8. DOI: 10.1016/S0022-3476(89)80604-3. PMID: 2783344.

19. van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013; 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Ann Rheum Dis. 72:1747–55. DOI: 10.1136/annrheumdis-2013-204424. PMID: 24092682.